Frank della Fera
Director/Board Member at LSL PHARMA GROUP INC.
Net worth: 383 979 $ as of 2024-04-29
Profile
Frank J.
della Fera is the President & Chief Executive Officer at Fera Pharmaceuticals LLC, a Director at LSL Pharma Group, Inc., and a former Vice President-Sales & Marketing at Eon Labs, Inc. He previously held positions as Sales Director at Dura Pharmaceuticals, Inc., Director at Grenville Baker Boys & Girls Club, Inc., Principal at Eli Lilly & Co., Vice President-Sales & Marketing at Sandoz, Inc., and Principal at Ben Venue Laboratories, Inc. He received his undergraduate degree from St. John's University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
LSL PHARMA GROUP INC
1.57% | 2024-04-22 | 1,292,857 ( 1.57% ) | 383 979 $ | 2024-04-29 |
Frank della Fera active positions
Companies | Position | Start |
---|---|---|
LSL PHARMA GROUP INC. | Director/Board Member | - |
Eon Labs, Inc.
Eon Labs, Inc. Pharmaceuticals: MajorHealth Technology Eon Labs, Inc. manufactures pharmaceuticals and generic drugs. They produce drugs in oral dosage variety and in both immediate and extended release delivery systems. Their products are used in treating arthritis, ulcers, epilepsy, infections and obsessive-compulsive disorder. The company was founded in 1992 and is headquartered in Lake Success, NY. | Sales & Marketing | - |
Fera Pharmaceuticals LLC
Fera Pharmaceuticals LLC BiotechnologyHealth Technology Fera Pharmaceuticals LLC is a privately held specialty pharmaceutical company located in the US. The American company's goal is to realize opportunities through acquisitions, in-licensing, and developing and marketing various drug applications. Fera Pharmaceuticals is committed to expanding treatment choices in ophthalmology and other therapeutic areas, with a focus on niche markets. The CEO of the company is Frank J. della Fera. | Chief Executive Officer | - |
Former positions of Frank della Fera
Companies | Position | End |
---|---|---|
Grenville Baker Boys & Girls Club, Inc. | Director/Board Member | - |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Chief Executive Officer | - |
Ben Venue Laboratories, Inc.
Ben Venue Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Ben Venue Laboratories, Inc. develops and manufactures sterile liquid products. Its products include Lyophilized Dosages, Small Molecule Pharmaceuticals, Cytotoxics, and Potent Compounds. The company was founded by R. Templeton Smith in 1938 and is headquartered in Bedford, OH. | Corporate Officer/Principal | - |
ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Dura Pharmaceuticals, Inc.
Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Dura Pharmaceuticals, Inc. markets and sells prescription products that treat infectious and respiratory diseases. Dura focuses on products and transactions that leverage its sales and marketing organization. Dura also intends, through the use of collaborative relationships, to develop the Spiros® motorized blisterdisk and Spiros® S2 pulmonary drug delivery systems for the local and systemic delivery of a wide range of medications. It is located in San Diego, CA. | Sales & Marketing | - |
Training of Frank della Fera
St. John's University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
LSL PHARMA GROUP INC. | Health Technology |
Private companies | 6 |
---|---|
Dura Pharmaceuticals, Inc.
Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Dura Pharmaceuticals, Inc. markets and sells prescription products that treat infectious and respiratory diseases. Dura focuses on products and transactions that leverage its sales and marketing organization. Dura also intends, through the use of collaborative relationships, to develop the Spiros® motorized blisterdisk and Spiros® S2 pulmonary drug delivery systems for the local and systemic delivery of a wide range of medications. It is located in San Diego, CA. | Health Technology |
Ben Venue Laboratories, Inc.
Ben Venue Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Ben Venue Laboratories, Inc. develops and manufactures sterile liquid products. Its products include Lyophilized Dosages, Small Molecule Pharmaceuticals, Cytotoxics, and Potent Compounds. The company was founded by R. Templeton Smith in 1938 and is headquartered in Bedford, OH. | Health Technology |
Eon Labs, Inc.
Eon Labs, Inc. Pharmaceuticals: MajorHealth Technology Eon Labs, Inc. manufactures pharmaceuticals and generic drugs. They produce drugs in oral dosage variety and in both immediate and extended release delivery systems. Their products are used in treating arthritis, ulcers, epilepsy, infections and obsessive-compulsive disorder. The company was founded in 1992 and is headquartered in Lake Success, NY. | Health Technology |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Health Technology |
Grenville Baker Boys & Girls Club, Inc. | |
Fera Pharmaceuticals LLC
Fera Pharmaceuticals LLC BiotechnologyHealth Technology Fera Pharmaceuticals LLC is a privately held specialty pharmaceutical company located in the US. The American company's goal is to realize opportunities through acquisitions, in-licensing, and developing and marketing various drug applications. Fera Pharmaceuticals is committed to expanding treatment choices in ophthalmology and other therapeutic areas, with a focus on niche markets. The CEO of the company is Frank J. della Fera. | Health Technology |
- Stock Market
- Insiders
- Frank della Fera